Rapid Novor Inc.: federal grants and contributions: 15 agreements; $1.3M value; 2 departments; 5 programs.
Assay record ASY-CA-0P6KV771MI · Cite as: Assay Systems, “Rapid Novor Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/rapid-novor-inc/
This project will develop a new protein sequencing workflow which incorporates a robotic liquid handling and triage assessment system. Establishment of the new workflow will make our firm one of the first automated protein sequencing facilities and double the throughput of sequincing process.
We will develop and implement a new in-house Ig-Sequencing platform that can be integrated with our proteomics tools to fully assess immune responses in rabbits. The new platform will enable the commercialization of the REpAb service to deliver antibody sequence data that helps customers expedite therapeutic development.
We will use our antibody protein sequencing technology to deliver antibody sequences from human donors recovered from COVID-19 to expedite therapeutic development, and in turn begin establishing an antibody bank for coronavirus and future pandemic surveillance.
This project will allow us to focus on the development of an early-stage lead generation funnel to accelerate sales and foster continuous company growth. In this project, we will pursue content creation, promotional work, SEO, and market research, with the goal of attracting, nurturing, and increasing the volume of leads in the early stages of their buying journey. Ultimately this will lead to increased lead flow, and increased revenue.
Rapid Novor is expanding beyond its antibody sequencing work and offering new services for in-depth antibody characterization through HDX epitope mapping and SPR kinetic analysis. The client knows how clients interact with its sequencing services and need to learn how to conduct value-added marketing and sales to commercialize its new antibody characterization services. The client will learn and implement new upselling and cross-selling marketing and sales strategies to increase market awareness and sales opportunities for its new SPR and HDX services.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
This project will allow us to interview our customers to determine the voice of customers, to determine customer personas, to perform market analysis, to identify lead generation (outbound) strategies and improve our sales & marketing processes.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
We plan to expand our business by increasing our sales and brand awareness in the EU in addition to fostering relationships with European MM clinicians. We will conduct market research, travel for meetings and attend 2 trade shows.
This project aims to develop the EU market for Rapid Novor Inc's REmAb service, based on the experiences gained from the US market. This will greatly improve the company's competitiveness in EU and increase revenue from the region.
The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.